Dianthus Therapeutics raises ~$673.5M in public offering of common stock and pre-funded warrants

Dianthus Therapeutics, Inc. /DE/

Offering of 7,313,582 shares at $81.00/share and pre-funded warrants for 402,468 shares at $80.999/share.
Underwriters exercised in full option to purchase additional 1,157,407 shares on March 11, 2026.
Net proceeds expected to be approximately $673.5 million after underwriting discounts and expenses.
Offering expected to close March 12, 2026; securities offered under shelf registration statement.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.